Artwork runs in English
Label artwork, on-pack copy and retail packaging for United Kingdom are written in English. Plan translation and claims review alongside sampling so production is not waiting on artwork.
Private-label nutraceutical manufacturing — formulation depth across actives, blends and supplement formats, managed through one production platform. Formula, specification, samples and documentation move through one structured order workflow, reviewed for UK brands. The brand owner remains the food business operator on pack.
How to choose a manufacturing partner for UK brands — a reviewed catalogue, documentation by stage, and one structured order workflow.
DAT Supply manufactures private-label food supplements for UK brands across a multi-format platform.
Three things matter most: a reviewed formula base, a documented specification process, and a clear target-market claims review — before a sample is ever produced.
A private-label catalogue option that has already been through formulation review, rather than a formula built from zero for every enquiry.
Specification, label and batch documents released at defined project stages — not bundled into a single opaque handoff at the end.
On-pack copy and claim wording reviewed against the framework that applies for UK brands, before artwork is locked.
Brands for UK brands typically weigh a local co-packer against an EU-wide or international manufacturing platform. Neither is right by default — it depends on volume, format range and how many markets the brand plans to enter.
Can suit a single-market launch with a narrow format range and simple logistics — but often means re-briefing from scratch when the brand adds a second market or a second format.
One structured order workflow across formats and markets, with documentation reviewed per project against each target-market framework — useful once a brand plans to sell beyond a single market.
A single contracting party for the full private-label build: formula, specification, samples, documentation and production, managed through one client workspace.
Gummies, sachets, functional jellies, oral strips and pet soft chews run through the same order workflow, so a concept can move between formats without re-briefing.
Each project moves through defined review steps — brief, spec, artwork, release — inside one client workspace, not a vendor inbox.
Format is chosen against the brief. The same concept can move between packaging types without re-briefing.
Pectin-based supplement gummies — the mature DAT Supply format. Used across daily wellness, beauty, sleep and kids ranges.
Single-serving powder sachet / stick format for powders, granulates and mix-in daily-routine concepts. Configuration confirmed per project.
Pouchable functional jelly format for daily-routine and on-the-go supplement concepts.
Fast-dissolving oral strip format. Reviewed per project; payload range confirmed during the brief.
Dropper-bottle supplement format for oil-soluble or precise-dose actives.
Soft, paste-based chew format for cats and dogs. Format and palatability confirmed per project — no pet therapeutic claims.
Private-label catalogue
Your brand on a reviewed catalogue option. Project-specific personalisation is reviewed after order start.
Qualified custom development
A formula developed against your brief for qualified 5,000+ unit projects, after a paid feasibility/R&D review.
Final option, packaging configuration and minimum order quantity are confirmed against your brief inside the portal. Final timeline is confirmed during order setup.
Ready sample kits or development samples let you confirm texture, finish and packaging before committing to a full order.
Packaging options include PET bottle, doypack, blister and sachet, with pack configuration confirmed per project. Samples are ordered inside the DAT Supply portal, ahead of the full production run.
Each step is reviewed before the next review step opens.
Target format, quantity and claims direction, reviewed for UK brands.
Private-label catalogue or qualified custom development — confirmed against the brief.
Per-SKU specification + allergen statement drafted, then locked.
Confirm format, finish and packaging with a sample before the full run.
Dieline + on-pack copy reviewed against the target-market framework.
Production runs through the controlled workflow; batch-release documents issued after QC release.
Each document is released to the brand owner at its project stage. The Certificate of Analysis is batch-specific and issued after production — available on request, not as a standing public list.
DAT releases the standard documentation package by project stage. External testing, full COA, additional microbiological reports, heavy metals, pesticide residue reports or raw-material supplier documentation are reviewed and quoted separately unless included in the agreed project scope.
Production is reviewed against the relevant EU/UK food-supplement framework: NRV-based labelling and permitted-claim wording are checked per project before artwork is locked. The brand owner remains the food business operator and importer of record on pack. Claim wording reviewed against EU 1924/2006 and 432/2012 before production.
United Kingdom is a 67 million-person market with London as its administrative capital and London as its largest commercial city. Key commercial cities include London, Manchester, Birmingham, Glasgow, Liverpool. The working language for label artwork, regulatory submission and retail packaging is English. Retail distribution flows through Boots, Holland & Barrett, Superdrug pharmacy chains, Tesco, Sainsbury's and Waitrose grocery, and a mature DTC ecosystem led by London-based supplement brands. On the supplement industry signal: Post-Brexit divergence in NRVs + allergen formatting + FBO addressing; Boots / Holland & Barrett anchor pharmacy + specialist retail channels. For brand owners briefing DAT Supply, United Kingdom is positioned as a regulated EU food-supplement market: artwork is produced in English, the food business operator (typically the brand owner) carries label responsibility under the EU Reg. 1169/2011 framework, and the notification is filed with the country's competent authority (see the Regulatory framework section). DAT coordinates manufacturing, documentation and shipping under a single project so the brand owner can focus on demand generation, retail placement and the post-launch reorder cycle. The country's neighbours and natural cross-launch pairs for a single artwork project are listed under the internal links below.
Dietary supplements in United Kingdom are regulated as a category of food. The framework rests on EU Directive 2002/46/EC (food supplements), EU Reg. 1169/2011 (food information to consumers) and EU Reg. 1924/2006 / 432/2012 (nutrition and health claims), transposed nationally as Retained EU Law 1924/2006 (nutrition and health claims) and 1169/2011 (food information). Notification authority and route: FSA + DHSC. No central notification; food business operator responsibility under Retained EU Law. The brand owner is the food business operator and carries label responsibility — DAT supplies the documentation pack but does not file on the brand owner's behalf. Label-language requirement: English (UK English spelling). Allergen labelling: UK FIC allergen labelling (the 14 allergens) plus PARNUTS legacy guidance for certain categories. Novel ingredients: the UK FSA novel food authorisation register is now separate from the EU register following EU exit. Claim wording is the most-reviewed surface of the artwork pack. Permitted health claims are drawn from the EU 432/2012 register and any on-hold claims awaiting EFSA opinion; structure-function copy that does not assert disease prevention, treatment or cure is reviewed against the boundary set by Article 7 of Reg. 1169/2011 and the national authority's published guidance. Common rejection patterns: (i) implied disease-treatment phrasing on energy, sleep or stress SKUs, (ii) un-permitted comparative claims against medicines, (iii) using authorised-claim wording on products that do not meet the conditions of use, and (iv) translated claim wording that drifts from the authorised phrasing. DAT's artwork gate cross-references every claim on the pack against the authorised register or the national authority's borderline guidance before the brand owner files. Distinctive United Kingdom signal: pharmacist gate-keeping at Boots and Holland & Barrett shapes acceptable claim phrasing; the FSA novel-food list now diverges from the EU. Certification panel commonly seen on United Kingdom pack: Vegan Society, Vegetarian Society, Soil Association organic and kosher / halal where the brief requires it. Where certification is desired the brand owner provides the certificate and DAT confirms compliance against the certifier's scheme during the documentation pack assembly. Retailer-specific documentation expectations: pharmacy, drugstore and grocery buyers commonly request the technical dossier (formulation specification, raw-material specifications, microbiological release criteria, stability summary, allergen statement, country-of-origin declaration, certificate of GMP-aligned manufacturing) before listing a new SKU. DAT supplies the dossier as a single packaged set so the brand owner can present a complete file at the listing meeting. Post-launch obligations: the food business operator records and investigates any adverse events through the national vigilance route, maintains the technical file for the legal retention period (commonly five years from last batch shelf life), and keeps the artwork in step with any future authoritative re-interpretation of claim wording on the authorised register. DAT supports the brand owner through batch-by-batch documentation and an artwork variant track when the register changes.
Notification authority: FSA + DHSC
Label artwork, on-pack copy and retail packaging for United Kingdom are written in English. Plan translation and claims review alongside sampling so production is not waiting on artwork.
Food-supplement notification for United Kingdom is filed with FSA + DHSC. The notification and final on-pack claims remain the brand owner's responsibility; DAT supplies the supporting product documentation.
Post-Brexit divergence in NRVs + allergen formatting + FBO addressing; Boots / Holland & Barrett anchor pharmacy + specialist retail channels Reading the United Kingdom signal for a brand owner brief: the working language is English; the pharmacy, grocery, specialty health-food retail and DTC channel mix shapes pack format and unit economics; the notification authority (FSA + DHSC) sets the regulatory cadence; and the cert panel commonly seen on United Kingdom pack is Vegan Society, Vegetarian Society, Soil Association organic and kosher / halal where the brief requires it. The most distinctive United Kingdom working signal is that pharmacist gate-keeping at Boots and Holland & Barrett shapes acceptable claim phrasing; the FSA novel-food list now diverges from the EU.
Nutraceutical brand owners for UK brands usually scope a launch against a channel mix rather than a single buyer. Pharmacy chains and specialist health retailers such as Boots and Holland & Barrett anchor shelf presence, sitting alongside grocery, specialty health-food, and a direct-to-consumer lane. Each shapes pack format and unit economics differently: pharmacy and specialist retail reward a certification panel — Vegan Society, Vegetarian Society, Soil Association organic, plus kosher or halal where required — while the DTC lane tolerates smaller runs and subscription-friendly counts. Deciding which channel leads first tells the contract manufacturer which format, count, and cert marks to plan around.
Running the nutraceutical lane for UK brands turns on a notification pathway with no central filing: there is no single portal to notify, so responsibility sits with the food business operator under Retained EU Law, with FSA and DHSC as the reference authorities. That shifts documentation onto the brand owner stage by stage rather than a gatekeeping submission. Artwork works in English, the working language, but post-Brexit divergence means NRVs, allergen formatting, and FBO addressing are set for UK brands specifically — not lifted from an EU pack. Any novel ingredient is checked against the FSA novel-food list, which now diverges from the EU, before formulation locks.
There is no central notification. Under Retained EU Law the food business operator carries responsibility, with FSA and DHSC as the reference authorities, so the work is documentation held by the brand owner stage by stage rather than a pre-market filing. A contract manufacturer supplies specs and evidence for that dossier; the FBO addressing on pack must be set for UK brands.
Copy stays in English, but post-Brexit divergence means you cannot lift an EU pack. NRV percentages, allergen formatting, and FBO addressing are reset for UK brands, and any novel ingredient is screened against the FSA novel-food list, which now diverges from the EU. Those checks feed the artwork stage before print files lock.
Private-label catalogue orders start from 1,000 units. Qualified custom development volumes are confirmed after the development scope. Final quantities are confirmed against your brief inside the portal.
Yes. Ready sample kits or development samples let you confirm format, finish and packaging before you start a full order.
Claim wording reviewed against EU 1924/2006 and 432/2012 before production.
By project stage — specification and label first, then batch-release documents and a batch-specific Certificate of Analysis after production and QC release.
Create your account, complete your company profile and brief your order inside the DAT Supply portal. Format, route and minimum order quantity are confirmed once your brief has been reviewed.